These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8923308)

  • 1. Cerebral venous thrombosis and activated protein C resistance.
    Sánchez del Rio M; Gómez-Tortosa E; Outeriño J
    J Neurol; 1996 Oct; 243(10):727-8. PubMed ID: 8923308
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activated protein C resistance in factor V disease: how high is the risk of thrombosis?].
    Spannagl M; Schramm W
    Dtsch Med Wochenschr; 1998 Feb; 123(6):137-9. PubMed ID: 9505951
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebral venous thrombosis. Role of activated protein C resistance and factor V gene mutation.
    Brey RL; Coull BM
    Stroke; 1996 Oct; 27(10):1719-20. PubMed ID: 8841316
    [No Abstract]   [Full Text] [Related]  

  • 4. Bilateral renal vein thrombosis and venous sinus thrombosis in a neonate with factor V mutation (FV Leiden).
    Pohl M; Zimmerhackl LB; Heinen F; Sutor AH; Schneppenheim R; Brandis M
    J Pediatr; 1998 Jan; 132(1):159-61. PubMed ID: 9470020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R; Ens GE
    Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activated protein C resistance: role in venous and arterial thrombosis].
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated protein C resistance as a "new" cause of deep venous thrombosis in aviators.
    Emonson DL
    Aviat Space Environ Med; 1997 Jul; 68(7):606-8. PubMed ID: 9215466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation factor V gene mutation associated with activated protein C resistance leading to recurrent thrombosis, leg ulcers, and lymphedema: successful treatment with intermittent compression.
    Peus D; von Schmiedeberg S; Pier A; Scharf RE; Wehmeier A; Ruzicka T; Krutmann J
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 2):306-9. PubMed ID: 8698912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing for resistance to activated protein C factor V R506Q.
    Mack R; Albanese E; Fernandes H
    Arch Pathol Lab Med; 1998 Dec; 122(12):1046. PubMed ID: 9870848
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebral haemorrhagic infarction in young patients with hereditary protein C deficiency: evidence for "spontaneous" cerebral venous thrombosis.
    Wintzen AR; Broekmans AW; Bertina RM; Briët E; Briët PE; Zecha A; Vielvoye GJ; Bots GT
    Br Med J (Clin Res Ed); 1985 Feb; 290(6465):350-2. PubMed ID: 3917815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activated protein C resistance and mutation of coagulation factor V].
    Samama MM
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):669-70. PubMed ID: 8760650
    [No Abstract]   [Full Text] [Related]  

  • 12. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to activated protein C and a novel factor V gene mutation.
    Voelkerding KV
    Clin Lab Med; 1996 Mar; 16(1):169-86. PubMed ID: 8867589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis.
    Deschiens MA; Conard J; Horellou MH; Ameri A; Preter M; Chedru F; Samama MM; Bousser MG
    Stroke; 1996 Oct; 27(10):1724-30. PubMed ID: 8841318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden.
    Hirsch DR; Mikkola KM; Marks PW; Fox EA; Dorfman DM; Ewenstein BM; Goldhaber SZ
    Am Heart J; 1996 Jun; 131(6):1145-8. PubMed ID: 8644593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of factor V Leiden in African-Americans.
    Mack R; Samaan P; Podolak I; Albanese E
    Res Commun Mol Pathol Pharmacol; 1998 Mar; 99(3):339-43. PubMed ID: 9591328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The factor V Leiden mutation: spectrum of thrombotic events and laboratory evaluation.
    Bontempo FA; Hassett AC; Faruki H; Steed DL; Webster MW; Makaroun MS
    J Vasc Surg; 1997 Feb; 25(2):271-5; discussion 276. PubMed ID: 9052561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal purpura fulminans in association with factor V R506Q mutation.
    Pipe SW; Schmaier AH; Nichols WC; Ginsburg D; Bozynski ME; Castle VP
    J Pediatr; 1996 May; 128(5 Pt 1):706-9. PubMed ID: 8627449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative PCR method for diagnosis of mutation causing activated protein C resistant Gln506-factor V.
    Greengard JS; Xu X; Gandrille S; Griffin JH
    Thromb Res; 1995 Dec; 80(5):441-3. PubMed ID: 8588206
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance to activated protein C and Arg 506 Gln factor V mutation are uncommon in eastern Asian populations.
    Kodaira H; Ishida F; Shimodaira S; Takamiya O; Furihata K; Kitano K
    Acta Haematol; 1997; 98(1):22-5. PubMed ID: 9210909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.